Skip to main content
. 2017 Nov 15;8(66):109877–109888. doi: 10.18632/oncotarget.22436

Figure 3. Relationship between extracellular miR-224 expression and prognosis.

Figure 3

Patients were divided to two groups of 54 according to median extracellular miR-224 expression. (A) Kaplan-Meier plot of progression-free survival (PFS). High exo-miR-224 group had significantly worse PFS than the low exo-miR-224 group (Log-rank P < 0.0001). (B) Kaplan-Meier plot of cancer-specific survival (CSS). High exo-miR-224 group had significantly worse CSS than the low exo-miR-224 group (Log-rank P = 0.0072). (C) Kaplan-Meier plot of overall survival (OS). High exo-mi-224 group had significantly worse PFS than the low exo-miR-224 group (Log-rank P = 0.0046). (D) ROC curve of progression using extracellular miR-224 (AUC: 0.833). Extracellular miR-224 was a good marker for progression. (E) ROC curve of cancer-specific mortality using extracellular miR-224 (AUC: 0.863). Extracellular miR-224 was good marker for cancer specific mortality. (F) ROC curve of overall survival using extracellular miR-224 (AUC: 0.857). Extracellular miR-224 was good marker for overall survival.